End-of-Life Discussions With Patients and Caregivers Affected By Neurogenetic Diseases.
Anne-Claire DorsemansGiulia CoarelliAnna HeinzmannBenoit VerdonDe Luca ManuellaElodie PetitLucie PierronMichèle Levy-SoussanAlexandra DurrMarcela GargiuloClaire EwenczykPublished in: Neurology. Clinical practice (2023)
Being affected by severe neurogenetic diseases does not seem to prompt individuals to give much thought to end-of-life planning. However, patients and caregivers welcome comprehensive information and expect progressive support from trained health care professionals in having such discussions. Routine integration of these conversations into medical management through a holistic and adapted approach will benefit patients with illnesses with unfavorable long-term prognoses.